NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.56
-0.36 (-4.04%)
At close: Mar 10, 2026, 4:00 PM EDT
8.51
-0.05 (-0.58%)
Pre-market: Mar 11, 2026, 5:16 AM EDT

NeoGenomics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-108.03-78.73-87.97-144.25-8.35
Depreciation & Amortization
67.8272.5572.5869.4353.35
Stock-Based Compensation
41.3233.4124.6324.6722.46
Other Adjustments
36.2112.4214.2915.86-89.59
Change in Receivables
-6.18-19.31-11.52-7.58-4.69
Changes in Inventories
-1.54-2.7-0.45-1.11.63
Changes in Accounts Payable
-4.69-4-4.550.967.71
Changes in Accrued Expenses
-15.679.2813.021.8411.61
Changes in Income Taxes Payable
-3.36-3.07-11.19-16.1-6.3
Changes in Other Operating Activities
-0.66-12.83-10.8-9.72-14.57
Operating Cash Flow
5.237.02-1.95-65.99-26.72
Operating Cash Flow Growth
-25.53%----
Capital Expenditures
-27.01-41.06-28.75-30.89-64.14
Purchases of Investments
-1--6.76-97.61-196.79
Proceeds from Sale of Investments
20.0653.92112.22116.9262.97
Payments for Business Acquisitions
-6.45----419.4
Proceeds from Business Divestments
2.07--12.1-
Other Investing Activities
-----15
Investing Cash Flow
-12.3412.8676.710.52-632.37
Long-Term Debt Issued
----334.41
Long-Term Debt Repaid
-201.25--0.07-0.76-3.05
Net Long-Term Debt Issued (Repaid)
-201.25--0.07-0.76331.36
Issuance of Common Stock
0.964.654.6212.59423.21
Net Common Stock Issued (Repurchased)
0.964.654.6212.59423.21
Other Financing Activities
-----29.29
Financing Cash Flow
-200.294.654.5511.83725.29
Net Cash Flow
-207.3924.5279.31-53.6566.2
Free Cash Flow
-21.78-34.04-30.71-96.88-90.87
FCF Margin
-2.99%-5.15%-5.19%-19.01%-18.76%
Free Cash Flow Per Share
-0.17-0.27-0.24-0.78-0.76
Levered Free Cash Flow
-294.38-60.56-58.18-130.59312.32
Unlevered Free Cash Flow
-98.62-71.71-67.75-128.27-76.45
Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q